Navigo Proteins
Business Services · Germany · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Heinrich-damerow-strasse 1, Halle, Saxon...Phone Number
+49 34527996330Website
www.navigo-proteins.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Navigo Proteins
Navigo Proteins is an innovative biotech company based in Germany, focused on advancing sustainable innovation in the life sciences sector. The company specializes in developing bioprocessing solutions for the biotherapeutics industry and pioneering targeted therapies for diseases with significant unmet medical needs. Through its core subsidiaries and asset vehicles, Navigo Proteins collaborates with independent companies to enhance patient diagnosis and treatment options. Their initiatives include developing radiotheranostic products for oncology and cutting-edge therapies for chronic ophthalmic diseases.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Navigo Proteins your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Navigo Proteins launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Navigo Proteins recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if Navigo Proteins is spiking on competitors!
Check if Navigo Proteins has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Navigo Proteins
Click to see if Navigo Proteins had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Navigo Proteins has new funding data
Navigo Proteins, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Navigo Proteins as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Navigo Proteins is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Navigo Proteins is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Navigo Proteins.
Navigo Proteins financials insights
Gather financial insights about Navigo Proteins, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Unspecified
$33.1M
Navigo Proteins Tech Stack
A closer look at the technologies used by Navigo Proteins
Most Recent Scoops
Person-Based
Person-Based
Open Position
Open Position
Navigo Proteins News & Media
ITM and Navigo Proteins Announce Research Collaboration to Develop FAP-targeting Radionuclide Therapy to Address Solid Tumors
GARCHING, Germany & MUNICH & HALLE, Germany--(BUSINESS WIRE)--ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company and Navigo Proteins GmbH, a premier protein engineering company developing optimized scaffold protein-based affinity ligands called Affilin® molecules from its Precision Targeting toolbox, today announced a research collaboration for the development of a fibroblast activation protein (FAP)-targeted radiopharmaceutical program for the treatment of solidRepligen and Navigo GmbH Announce Launch of Industry-First Protein A Ligand for Purification of pH Sensitive Antibodies
WALTHAM, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, and Navigo Proteins GmbH (“Navigo”), today announced they have completed development and validation of a novel protein A ligand that overcomes challenges associated with the purification of pH sensitive antibodies and Fc-fusion proteins. Named NGL-Impact® A Hi pH, the new ligand is the first to address antibody aggregation in low pH elutioRepligen and Navigo Proteins Announce Achievement of Key Milestone in Developing an Affinity Resin for the Purification of COVID-19 Vaccines
WALTHAM, Mass. and HALLE (Saale), Germany, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, and Navigo Proteins GmbH (“Navigo”), a premier protein engineering company specializing in novel affinity ligand development, today announced their successful development of an affinity ligand targeting the spike protein, to be utilized in the purification of COVID-19 vaccines. The program has entered stage two, w
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Navigo Proteins
Sign Up For FreeTo access detailed company insights
Navigo Proteins is an innovative biotech company based in Germany, focused on advancing sustainable innovation in the life sciences sector. The company specializes in developing bioprocessing solutions for the biotherapeutics industry and pioneering targeted therapies for diseases with significant unmet medical needs. Through its core subsidiaries... Read More
